¿¬¼ö°­ÁÂ
2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 3ÀÏÂ÷ : 2024-04-13

2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 3ÀÏÂ÷ : 2024-04-13
±³À°ÀÏÀÚ : 2024-04-13
±³À°Àå¼Ò : ¿©¼ö ¿¢½ºÆ÷ ÄÁº¥¼Ç¼¾ÅÍ ¿¢½ºÆ÷Ȧ ¹× ±×·£µåȦ

±³À°ÁÖÁ¦ : 2024³â ´ëÇѸ鿪ÇÐȸ 50Áֳ⠱â³ä Ãá°èÇмú´ëȸ 3ÀÏÂ÷

ÁÖÃÖ±â°ü : ´ëÇѸ鿪ÇÐȸ
´ã´çÀÚ : ±èÁÖ¿¬
¿¬¶ôó : 02-2038-8555  

À̸ÞÀÏ : kai@kaimm.org

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°­ÀÇÇаú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, »ê¾÷ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú, ÀÇ»çÇÐ, ¹ýÀÇÇÐ, ¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ±â»ýÃæÇÐ, ¾à¸®ÇÐ, ÀÇÇб³À°, ±âŸ

Âü¼®¿¹»óÀÎ : 900¸í
Èñ¸ÁÆòÁ¡ : 2Á¡

Áö¿ª : Àü¶ó³²µµ
±³À°½Ã°£ : 2 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 280,000¿ø  

ºñ°í "»çÀüµî·Ï

Çлýȸ¿ø 10¸¸¿ø, ȸ¿ø 14¸¸¿ø, ºñȸ¿ø 25¸¸¿ø 

ÇöÀåµî·Ï 

Çлýȸ¿ø 13¸¸¿ø, ȸ¿ø 17¸¸¿ø, ºñȸ¿ø 28¸¸¿ø" 


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 08:50~09:10 Harnessing non-invasive immune cell characterization in lung cancer patients. ·ùÈñÁÖ(¼º±Õ°ü´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 09:10~09:30 Cytokine (IL-2)-independent role of IL2RA (CD25) in B-cell homeostasis ÀÌÀç¿õ(°í·Á´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 09:30~09:50 Understanding Interactions of Microbe-Epithelia-Immune System Àå°æ±¸(¿¬¼¼´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 09:50~10:10 Discovery of Innate immune modulator in the PANoptosis and Cytokine strorm ÇÑÁÖÈñ(¿ì¼®´ë)

ÈÞ½Ä 04¿ù 13ÀÏ 10:10~10:40 ÈÞ½Ä ()

±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 10:40~11:00 Immunosurveillance of the Central Nervous System by Dural Macrophages ±è¿µÂù(¼­¿ï´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 11:00~11:20 Application of single cell RNA sequencing in the clinical diseases ÀÌ»óÁø(°æºÏ´ë)

±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 11:20~11:40 Epigenetic scars in immune cells during inflammatory diseases °íÁØ¿µ(Áö³ðÀλçÀÌÆ®)

±³À°½Ã°£ 04¿ù 13ÀÏ Room A (¿¢½ºÆ÷Ȧ) 11:40~12:00 Strategies to promote cellular immunotherapy outcome in multiple myeloma Á¶Çö¼ö(¿¬¼¼´ë)

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù) : 2024-05-18

±³À°ÀÏÀÚ : 2024-05-18 ±³À°Àå¼Ò : ¿Â¶óÀÎ (24½Ã°£ VOD ´çÀÏ ¼ÛÃâ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù)ÁÖÃÖ±â°ü : ¼­¿ïƯ

Ãßõ¼ö : 1 , Á¶È¸¼ö : 521 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ 16th Vascular Ultrasound Seoul Update 2023 Symposium (2ÀÏÂ÷) : 2024-04-21

±³À°ÀÏÀÚ : 2024-04-21 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø ÁöÇÏ 1Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 16th Vascular Ultrasound Seoul Update 2023

Ãßõ¼ö : 0 , Á¶È¸¼ö : 549 , ´ñ±Û¼ö : 0

[ºÎ»ê] ´ëÇÑ°ñÀýÇÐȸ Á¦50Â÷ Çмú´ëȸ(1ÀÏÂ÷) : 2024-04-26

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ ºÎ»ê ±³À°ÁÖÁ¦ : ´ëÇÑ°ñÀýÇÐȸ Á¦50Â÷ Çмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ°ñÀýÇÐȸ ´ã´çÀÚ : Á¤À¯Áø ¿¬¶ôó : 031-551

Ãßõ¼ö : 0 , Á¶È¸¼ö : 404 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (4¿ù) : 2024-04-20

±³À°ÀÏÀÚ : 2024-04-20 ±³À°Àå¼Ò : ¿Â¶óÀÎ (24½Ã°£ VOD ´çÀÏ ¼ÛÃâ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (4¿ù)ÁÖÃÖ±â°ü : ¼­¿ïƯ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 528 , ´ñ±Û¼ö : 1

[¼­¿ï] (¿Â¶óÀÎ) 2023³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù) : 2023-05-20

±³À°ÀÏÀÚ : 2023-05-20 ±³À°Àå¼Ò : ¿Â¶óÀÎ (VOD ´çÀÏ 24½Ã°£ ¼ÛÃâ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2023³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (5¿ù)ÁÖÃÖ±â°ü : ¼­¿ïƯ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,062 , ´ñ±Û¼ö : 0